There were 1,787 press releases posted in the last 24 hours and 359,333 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image